# A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects

> **NCT05913752** · PHASE1,PHASE2 · RECRUITING · sponsor: **Clearmind Medicine Inc.** · enrollment: 84 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** CMND-100

## Key facts

- **NCT ID:** NCT05913752
- **Lead sponsor:** Clearmind Medicine Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05913752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05913752, "A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05913752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*